Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).
Nancy U. Lin
Consultant or Advisory Role - Geron (U); GlaxoSmithKline; Novartis; to-BBB technologies BV (U)
Research Funding - Bayer; Genentech; Geron; GlaxoSmithKline; Novartis
Rebecca Sue Gelman
No relevant relationships to disclose
W. Jerry Younger
No relevant relationships to disclose
Jessica Sohl
No relevant relationships to disclose
Rachel A. Freedman
Research Funding - Puma Biotechnology
A. Gregory Sorensen
No relevant relationships to disclose
Elizabeth Bullitt
No relevant relationships to disclose
Gordon J Harris
No relevant relationships to disclose
Daniel Morganstern
No relevant relationships to disclose
Bryan P. Schneider
Consultant or Advisory Role - Genentech
Ian E. Krop
Research Funding - Genentech
Eric P. Winer
No relevant relationships to disclose